Sort By
Title Published Price Buy Now
China Pharmaceutical Distribution Industry Report, 2013
By Research In China
Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of roughly 20% in 2005-2013. As the leading pla...
Apr 2014 $ 2400
Research Report on Medical Industry in China, 2014-2018
By China Research and Intelligence
In China, medical institutions refer to licensed (the Practice License of Medical Institutions) hospitals, health centers, clinics and firstaid stations that diagnose and treat diseases. As a public service provider, medical institutions a...
Apr 2014 $ 2400
China Medical Informatization Industry Report, 2013-2016
By Research In China
Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, management information system has been basically esta...
Apr 2014 $ 1850
China Pharmaceutical Glass Packaging Industry Report, 2013-2016
By Research In China
Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceutical glass packaging industry develops sluggishl...
Apr 2014 $ 1500
China Aged Care Industry Report, 2013-2016
By Research In China
Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to 10.7% in 2016. Meanwhile, the rising old...
Mar 2014 $ 2400
Investigation Report on China Sildenafil Market, 2009-2018
By China Research and Intelligence
There are hundreds of millions of males suffering from sexual dysfunction in the world, of which over 50 million are in China. Statistics indicates that more than 60% of males aged above 35 in China have sexual dysfunction of different degrees. Ab...
Mar 2014 $ 1800
Investigation Report on China Valsartan Hydrochlorothiazide Market, 2009-2018
By China Research and Intelligence
According to WHO, onethird of the world's adults have hypertension. The global market value of antihypertensive drugs is tens of billion dollars. Due to the long history of antihypertensive drugs, most hypertensive patients need 2 or more ...
Mar 2014 $ 1800
Investigation Report on China Insulin Aspart Market, 2009-2018
By China Research and Intelligence
According to IDF (the International Diabetes Federation), incidence of diabetes among adults aged 2079 in the world was 8.3% in 2013 with more than 380 million patients worldwide. On December 26, 2001 Novo Nordisk announced that the first ...
Mar 2014 $ 1800
Investigation Report on China Insulin Lispro Market, 2009-2018
By China Research and Intelligence
According to IDF (the International Diabetes Federation), incidence of diabetes among adults aged 2079 in the world was 8.3% in 2013 with 382 million patients worldwide. The number of diabetes patients in China was more than 98 million, ranking th...
Mar 2014 $ 1800
China Chinese Patent Medicine Industry Report, 2013-2016
By Research In China
Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance with specified prescription and standard. Chin...
Mar 2014 $ 2200
Investigation Report on China Esomeprazole Market, 2009-2018
By China Research and Intelligence
Digestive system disease is one of the most frequently occurring diseases. According to statistics from WHO, there are at least 250 million people worldwide suffering from digestive system diseases, especially canker. Inhibition of gastric...
Mar 2014 $ 1800
Investigation Report on China Adalimumab Market, 2010-2018
By China Research and Intelligence
Adalimumab is a TNF (tumor necrosis factor) inhibiting antiinflammatory drug, the first fully human monoclonal antibody drug approved by the FDA. It was discovered through collaboration between BASF Bioresearch Corporation and Cambridge Antibody T...
Mar 2014 $ 1800
Investigation Report on China Pregabalin Market, 2009-2018
By China Research and Intelligence
Neuropathic pain is caused by damage or pathological changes of nervous system. Its main features are dull pain, aestus and tingling. About 1% of people worldwide have neuropathic pain. Epileptic seizures are the result of excessive and abnormal c...
Mar 2014 $ 1800
Investigation Report on China Epoetin Alfa Market, 2009-2018
By China Research and Intelligence
Epoetin alfa refers to erythropoietin (EPO), a hormonelike substance secreted by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative red blood ...
Mar 2014 $ 1800
Investigation Report on China Olmesartan Market, 2009-2018
By China Research and Intelligence
According to statistics from WHO, onethird of the world's adults have high blood pressure. Death toll of this disease equals to half of the total number caused by stroke and heart attack. Angiotensin II receptor antagonist (ABR) is an impo...
Mar 2014 $ 1800
Investigation Report on China Tiotropium Bromide Market, 2009-2018
By China Research and Intelligence
As the air becomes more contaminated, incidence of asthma and chronic obstructive pulmonary diseases also increases. Consequently, more market space is provided for relevant drug manufacturers. Asthma is a common multiple disease mainly ca...
Mar 2014 $ 1800
Investigation Report on China Imatinib Market, 2009-2018
By China Research and Intelligence
Incidence of chronic myelogenous leukemia (CML) varies in the world. The global incidence is about 10/1,000,000 while in China it is 4/1,000,000. CML takes up about 20% of leukaemia in China and 95% of chronic leukemia. CML patients vary from the ...
Mar 2014 $ 1800
Investigation Report on China Aripiprazole Market, 2009-2018
By China Research and Intelligence
Schizophrenia is a common mental disorder. Data shows that mental illness has exceeded cardiovascular system, respiratory diseases and malignant tumors and turns into the heaviest social burden. Statistics shows that by the end of 2013 there have ...
Mar 2014 $ 1800
Investigation Report on China Enoxaparin Sodium Market, 2009-2018
By China Research and Intelligence
Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of oxygen and infarction, and even tissue death. Twelve million peop...
Feb 2014 $ 1800
Investigation Report on China Tacrolimus Market, 2009-2018
By China Research and Intelligence
Tacrolimus, also named as "FK506" and "FR900506", was developed by Fujisawa Pharmaceutical Co., Ltd. (later became Astellas Pharma by merging with Yamanouchi Pharmaceutical Co., Ltd.). In June 1993, it was firstly approved to Japan with the trade ...
Feb 2014 $ 1800
Investigation Report on China Pemetrexed Market, 2009-2018
By China Research and Intelligence
Pemetrexed, originally developed by Eli Lilly and Company, is a multitargeted antimetabolite antitumor drug. This product is with huge growth potential in the market. Approved by FDA in February 2004, pemetrexed is to treat unresectable ma...
Feb 2014 $ 1800
Investigation Report on China Quetiapine Market, 2009-2018
By China Research and Intelligence
Schizophrenia is a common mental disorder. As a chronic disease, schizophrenia can lead to recurrent or persistent symptoms in most patients' whole life. As Chinese economy and society develops, life and work here has become increasingly stressful...
Feb 2014 $ 1800
Global and China Industrial Enzyme Industry Report, 2014-2016
By Research In China
In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small number of large enterprises with R & D and...
Feb 2014 $ 1800
Investigation Report on China Bevacizumab Market, 2009-2018
By China Research and Intelligence
Bevacizumab is an important kind of remedy for metastatic colon cancer, which belongs to humanized anti-VEGF monoclonal antibody. Approved by FDA, bevacizumab came into the market in 2004, with the brand name of "Avastin". Its main mechanism is to...
Feb 2014 $ 1800
Investigation Report on China Insulin Glargine Market, 2009-2018
By China Research and Intelligence
With the improvement of people's living standard and changing of lifestyles, as well as deepening of the aging of society, prevalence rate of diabetes keeps rising, making it the third most threatening chronic disease to human health after tumor a...
Feb 2014 $ 1800
Live Chat
Live Chat by Comm100